# Ryan Specialty Holdings share price today (Ryan Specialty Holdings, Inc., RYAN)

> Ryan Specialty Holdings, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. RYAN · Financials · Insurance - Specialty · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/ryan

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting better, from the last 12 quarters
- Price: $45.73 (−16.6% in a year)
- P/BV: 12.3× (higher than 73% of the last 5.1 years)
- Revenue (Jun 2026): $903 M (+7.4% on a year ago)
- Profit (Jun 2026): $42.3 M (−18.6% on a year ago)
- Net margin: 4.7% (−1.5 points on a year ago)
- ROE: 25%, FY25
- ROA: 3.79%, latest

Biggest thing to watch: the P/BV is higher than 73% of its own history, so the multiple has already done part of the work. ## What is the Ryan Specialty Holdings share price today? Ryan Specialty Holdings, Inc.'s share price was $45.73 at the close on 3 November 2026. It has been stalling near its high for 4 weeks. That is 17.5% above its average price over the last 200 trading days. In the last 52 weeks it traded between $31 and $58, and at that close it sat 55% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row. Over the last 5.3 years the share price moved +60% while the S&P 500 moved +71%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Ryan Specialty Holdings pay? Ryan Specialty Holdings, Inc. paid $0.50 per share over the last four reported quarters. The most recent declaration was $0.13 for Jun 2026. At today's price of $45.73 that is a yield of 1.09%, based on dividends already paid, not a forecast. ## Which stock lists is Ryan Specialty Holdings on? Ryan Specialty Holdings is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Ryan Specialty Holdings profitable? Ryan Specialty Holdings, Inc. earned $42.3 M of net profit in the Jun 2026 quarter, −18.6% on the same quarter a year earlier. Full-year FY25 profit was $63.4 M. That is 4.7% of the quarter's revenue. The same quarter a year earlier earned $52.0 M. 2 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $63.4 M (−33.0% on the year before). Why profit moved: revenue changed +7.4% on a year earlier and the margin moved −1.5 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +2.5% and revenue +15.6%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Ryan Specialty Holdings make, and is it growing? Ryan Specialty Holdings, Inc. reported $903 M of income in the Jun 2026 quarter, +7.4% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 20.2% a year on average. The last full year, FY25, came in at $3.0 B. The last four reported quarters add to $3.2 B. FY25 revenue was $3.0 B, +21.9% on the year before. Recent pace: the last four quarters grew +15.6% on average, against 20.2% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +14.8%, against +19.3% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +72.6%, against +12.5% a year (accelerating). ## How much does Ryan Specialty Holdings keep from what it earns? Ryan Specialty Holdings, Inc.'s net margin was 4.7% in the Jun 2026 quarter, 1.5 percentage points lower than the same quarter a year ago. Across 5 years it has been between −0.5% and 3.9%. The latest quarter is above every full year in that period. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of Ryan Specialty Holdings' loans have gone bad? Ryan Specialty Holdings, Inc. does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Ryan Specialty Holdings' loan book growing? Ryan Specialty Holdings, Inc.'s revenue was $3.0 B in FY25, +21.9% on the year before, so the loan book is growing. The latest quarter was +7.4% on a year earlier. The net margin on that income is 4.7%, −1.5 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. ## What is Ryan Specialty Holdings' P/BV ratio, and how does it compare with its own history? Ryan Specialty Holdings, Inc.'s P/BV is 12.3×, near the high end of its own history: higher than 73% of past readings. Its usual P/BV (the middle reading) is 11.0×, over 5.1 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year book value grew while the price moved −16.6%. The price ran ahead of book value, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved +4.2% a year; about +8.1% a year came from book-value growth and about −3.9 percentage points from the multiple (the market paying less). The split is approximate (price return minus book-value growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the book value trend underneath matters more than the multiple. ## Is the Ryan Specialty Holdings business getting better or worse? Ryan Specialty Holdings, Inc.'s business is getting better. EPS growth hit its low 4 quarters ago at −82.3% and has recovered to +650.4%, with ROE rising at 9.7%. This is based on 12 quarters of 4 measures. Why it matters: a lasting rise from a low is what this page is built to show. ## How much does Ryan Specialty Holdings earn on its equity and assets? Ryan Specialty Holdings, Inc. earned a return on equity of 5% in FY25. Its lowest yearly reading on file was −1% in FY21. On its assets, every $100 earned about $3.79, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That return is below the level a bank needs to grow its net worth quickly, which helps explain why its multiple is where it is. Why: the ROE chart shows the move, but the deposit-cost and bad-loan details behind it are not in our data. ## Does Ryan Specialty Holdings have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Ryan Specialty Holdings shareholding pattern? 13.4% of Ryan Specialty Holdings, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 6.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Ryan Specialty Holdings from balance-sheet trouble? For Ryan Specialty Holdings, Inc., the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Ryan Specialty Holdings rank in its industry? 65.8 out of 100, rank 3 of 17 in Insurance - Specialty, with 76% of the evidence available. Ryan Specialty Holdings, Inc. scores 65.8 out of 100 against the 17 companies it is compared with in Insurance - Specialty, ranking 3. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 27.9 + 15.3 + 3 + 19.6 = 65.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Ryan Specialty Holdings compared with? Ryan Specialty Holdings ranks 3 of 17 Insurance - Specialty companies on the 4-Factor Sector Score, with 65.8 out of 100. 1. [AXIS Capital Holdings Limited](https://www.sectoralpha.in/us/stocks/axs) AXS · turning · Most evidence points up · 76% evidence 68.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.2/35 · Income 9.1% · Profit 24.6% · 71% evidence Capital efficiency 16.7/25 · ROA 2.2% · ROE 16% · GNPA n/a · 68% evidence Valuation 14.9/20 · P/BV 1.22× · P/BV÷ROE 0.08 · 70% evidence Relative strength 15.2/20 · Lead over its industry 7.1% · Lead over S&P 500 -1.8% · 1 year 6.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.2 + 16.7 + 14.9 + 15.2 = 68 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [First American Financial Corporation](https://www.sectoralpha.in/us/stocks/faf) FAF · basing · Most evidence points up · 80% evidence 67.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Income 14.2% · Profit 52.1% · 81% evidence Capital efficiency 17.4/25 · ROA 4.5% · ROE 15.7% · GNPA n/a · 68% evidence Valuation 16.0/20 · P/BV 1.15× · P/BV÷ROE 0.07 · 70% evidence Relative strength 5.6/20 · Lead over its industry 1.1% · Lead over S&P 500 -7% · 1 year 4.2% · 100% evidence · 2 of 12 weeks ahead Exact sum: 28.7 + 17.4 + 16 + 5.6 = 67.7 · What this means: Earnings are strong; relative strength in its sector is 1.1% and the one-year return is 4.2%. 3. Ryan Specialty Holdings, Inc. this page RYAN · turning · Most evidence points up · 76% evidence 65.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.9/35 · Income 14.9% · Profit 73.7% · 71% evidence Capital efficiency 15.3/25 · ROA 3.2% · ROE 13.1% · GNPA n/a · 68% evidence Valuation 3.0/20 · P/BV 4.81× · P/BV÷ROE 0.37 · 70% evidence Relative strength 19.6/20 · Lead over its industry 14% · Lead over S&P 500 3.7% · 1 year -21.2% · 100% evidence · 5 of 12 weeks ahead Exact sum: 27.9 + 15.3 + 3 + 19.6 = 65.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [NMI Holdings, Inc.](https://www.sectoralpha.in/us/stocks/nmih) NMIH · quiet · Evidence leans up · 76% evidence 63.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Income 7.5% · Profit 4.5% · 71% evidence Capital efficiency 19.7/25 · ROA 8.5% · ROE 15.2% · GNPA n/a · 68% evidence Valuation 15.3/20 · P/BV 1.15× · P/BV÷ROE 0.08 · 70% evidence Relative strength 15.2/20 · Lead over its industry 11.9% · Lead over S&P 500 2.9% · 1 year 18.2% · 100% evidence · 5 of 12 weeks ahead Exact sum: 12.8 + 19.7 + 15.3 + 15.2 = 63 · What this means: Relative strength against the index is 2.9%, and revenue and profit growth are weak. 5. [Essent Group Ltd.](https://www.sectoralpha.in/us/stocks/esnt) ESNT · turning · Evidence leans up · 76% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.2/35 · Income 4.3% · Profit -4.6% · 71% evidence Capital efficiency 16.3/25 · ROA 7.1% · ROE 12% · GNPA n/a · 68% evidence Valuation 14.8/20 · P/BV 1.05× · P/BV÷ROE 0.09 · 70% evidence Relative strength 15.9/20 · Lead over its industry 11.1% · Lead over S&P 500 2.2% · 1 year 10.8% · 100% evidence · 5 of 12 weeks ahead Exact sum: 13.2 + 16.3 + 14.8 + 15.9 = 60.2 · What this means: Relative strength against the index is 2.2%, and revenue and profit growth are weak. 6. [Enact Holdings, Inc.](https://www.sectoralpha.in/us/stocks/act) ACT · quiet · Evidence leans up · 76% evidence 57.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.6/35 · Income 2.4% · Profit 0.7% · 71% evidence Capital efficiency 17.1/25 · ROA 8.1% · ROE 12.5% · GNPA n/a · 68% evidence Valuation 13.2/20 · P/BV 1.18× · P/BV÷ROE 0.1 · 70% evidence Relative strength 14.7/20 · Lead over its industry 13.1% · Lead over S&P 500 4.4% · 1 year 28.4% · 100% evidence · 5 of 12 weeks ahead Exact sum: 12.6 + 17.1 + 13.2 + 14.7 = 57.6 · What this means: Relative strength against the index is 4.4%, and revenue and profit growth are weak. 7. [Investors Title Company](https://www.sectoralpha.in/us/stocks/itic) ITIC · quiet · Evidence leans up · 76% evidence 55.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Income 8.1% · Profit 28.1% · 71% evidence Capital efficiency 14.4/25 · ROA 5.3% · ROE 9% · GNPA n/a · 68% evidence Valuation 7.0/20 · P/BV 1.8× · P/BV÷ROE 0.2 · 70% evidence Relative strength 9.4/20 · Lead over its industry 6.2% · Lead over S&P 500 -2.2% · 1 year -3.8% · 100% evidence · 5 of 12 weeks ahead Exact sum: 25.1 + 14.4 + 7 + 9.4 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Radian Group Inc.](https://www.sectoralpha.in/us/stocks/rdn) RDN · basing · Evidence leans up · 76% evidence 55.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.6/35 · Income 37.5% · Profit -8.7% · 71% evidence Capital efficiency 15.4/25 · ROA 5.8% · ROE 10.8% · GNPA n/a · 68% evidence Valuation 13.4/20 · P/BV 1.04× · P/BV÷ROE 0.1 · 70% evidence Relative strength 11.9/20 · Lead over its industry 5.3% · Lead over S&P 500 -3.2% · 1 year 2.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 14.6 + 15.4 + 13.4 + 11.9 = 55.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 9. [MGIC Investment Corporation](https://www.sectoralpha.in/us/stocks/mtg) MTG · basing · Evidence leans up · 76% evidence 52.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.5/35 · Income -1.8% · Profit -7.2% · 71% evidence Capital efficiency 17.8/25 · ROA 8.3% · ROE 13% · GNPA n/a · 68% evidence Valuation 13.6/20 · P/BV 1.19× · P/BV÷ROE 0.09 · 70% evidence Relative strength 11.2/20 · Lead over its industry 6.3% · Lead over S&P 500 -2.3% · 1 year 2.2% · 100% evidence · 5 of 12 weeks ahead Exact sum: 9.5 + 17.8 + 13.6 + 11.2 = 52.1 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 10. [Fidelity National Financial, Inc.](https://www.sectoralpha.in/us/stocks/fnf) FNF · basing · Evidence leans down · 76% evidence 47.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.0/35 · Income 12.6% · Profit -22.1% · 71% evidence Capital efficiency 13.8/25 · ROA 1.4% · ROE 14.5% · GNPA n/a · 68% evidence Valuation 11.9/20 · P/BV 1.44× · P/BV÷ROE 0.1 · 70% evidence Relative strength 2.4/20 · Lead over its industry -12.9% · Lead over S&P 500 -20.6% · 1 year -27.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19 + 13.8 + 11.9 + 2.4 = 47.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Octave Specialty Group, Inc.](https://www.sectoralpha.in/us/stocks/osg) OSG · turning · Too little evidence to rank firmly · 55% evidence 46.5 out of 100 Growth Capital Valuation Relative
12. [AMERISAFE, Inc.](https://www.sectoralpha.in/us/stocks/amsf) AMSF · basing · Evidence leans down · 76% evidence 38.4 out of 100 Growth Capital Valuation Relative
13. [Employers Holdings, Inc.](https://www.sectoralpha.in/us/stocks/eig) EIG · quiet · Evidence leans down · 76% evidence 36.1 out of 100 Growth Capital Valuation Relative
14. [Assured Guaranty Ltd.](https://www.sectoralpha.in/us/stocks/ago) AGO · basing · Most evidence points down · 76% evidence 31.9 out of 100 Growth Capital Valuation Relative
15. [Tiptree Inc.](https://www.sectoralpha.in/us/stocks/tipt) TIPT · turning · Too little evidence to rank firmly · 46% evidence 46.2 out of 100 Growth Capital Valuation Relative
16. [MBIA Inc.](https://www.sectoralpha.in/us/stocks/mbi) MBI · basing · Too little evidence to rank firmly · 45% evidence 39.5 out of 100 Growth Capital Valuation Relative
17. James River Group Holdings, Inc. JRVR · basing · Too little evidence to rank firmly · 47% evidence 29.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Insurance - Specialty](https://www.sectoralpha.in/us/sectors/insurance-specialty), all 17 compared on one page. ## Which companies are close to Ryan Specialty Holdings in size? Ryan Specialty Holdings is the largest of 16 Insurance - Specialty companies on Sector Alpha by market value (scores of 3 November 2026). It is the largest. Just below it: Fidelity National Financial, Inc., AXIS Capital Holdings, First American Financial Corporation, Enact Holdings, Inc., Essent Group and MGIC Investment Corporation. ### Insurance - Specialty companies close in size

1. Ryan Specialty Holdings, Inc. $11.5 billion
2. [Fidelity National Financial, Inc.](https://www.sectoralpha.in/us/stocks/fnf) $11.1 billion
3. [AXIS Capital Holdings Limited](https://www.sectoralpha.in/us/stocks/axs) $7.6 billion
4. [First American Financial Corporation](https://www.sectoralpha.in/us/stocks/faf) $6.6 billion
5. [Enact Holdings, Inc.](https://www.sectoralpha.in/us/stocks/act) $6.5 billion
6. [Essent Group Ltd.](https://www.sectoralpha.in/us/stocks/esnt) $6.1 billion
7. [MGIC Investment Corporation](https://www.sectoralpha.in/us/stocks/mtg) $5.9 billion

[All 16 Insurance - Specialty companies, largest first](https://www.sectoralpha.in/us/sectors/insurance-specialty#all-companies)

### Companies close in size in other industries

1. [U-Haul Holding Company](https://www.sectoralpha.in/us/stocks/uhal) $11.6 billion · Rental & Leasing Services
2. [Jack Henry & Associates, Inc.](https://www.sectoralpha.in/us/stocks/jkhy) $11.5 billion · Information Technology Services
3. Ryan Specialty Holdings, Inc. $11.4 billion
4. [Semtech Corporation](https://www.sectoralpha.in/us/stocks/smtc) $11.4 billion · Semiconductors
5. [UDR, Inc.](https://www.sectoralpha.in/us/stocks/udr) $11.4 billion · REIT - Residential

## What else do people ask about Ryan Specialty Holdings? ### What were Ryan Specialty Holdings's latest quarterly results? Ryan Specialty Holdings, Inc. reported total income of $903 M and net profit of $42.3 M for the Jun 2026 quarter. Income rose 7.4% and profit fell 18.6% compared with a year earlier. Earnings per share were $0.33 (as of 3 November 2026). ### What is Ryan Specialty Holdings's market cap? Ryan Specialty Holdings, Inc.'s market capitalisation is $11.5 B at a stock price of $45.73. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Ryan Specialty Holdings performing? Ryan Specialty Holdings, Inc.'s share price has been stalling near its high for 4 weeks. In its latest quarter, income rose 7.4% and profit fell 18.6% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 3 November 2026). ### Will Ryan Specialty Holdings's stock price go up? This page does not forecast Ryan Specialty Holdings, Inc.'s stock price. What it shows instead: the stock price is $45.73, and it has been stalling near its high for 4 weeks. Its P/BV of 12.3× is higher than 73% of its own last 5 years (as of 3 November 2026). ### Where is Ryan Specialty Holdings in its business cycle? Ryan Specialty Holdings, Inc.'s FY25 net margin was 2.1%, against a 5-year range of −0.5% to 3.9%: the middle of its own range, neither a peak nor a low. The latest quarter was 4.7%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Ryan Specialty Holdings story? Biggest thing to watch: the P/BV is higher than 73% of its own history, so the multiple has already done part of the work. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Ryan Specialty Holdings a stock worth studying right now? What the numbers show: Ryan Specialty Holdings, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.